Drug Metabolism and Disposition 2000-09-01

Synthesis and identification of the quaternary ammonium-linked glucuronide of 1-phenylimidazole in human liver microsomes and investigation of the human UDP-glucuronosyltransferases involved.

S C Vashishtha, E M Hawes, G McKay, D J McCann

Index: Drug Metab. Dispos. 28(9) , 1009-13, (2000)

Full Text: HTML

Abstract

1-Phenylimidazole was investigated as a potential model substrate with respect to formation of a quaternary ammonium-linked glucuronide (N(+)-glucuronide) at an aromatic type tertiary amine. A reference sample of the potential N(+)-glucuronide metabolite of 1-phenylimidazole was obtained by organic synthesis. The structural identity of the metabolite formed by incubation of 1-phenylimidazole with human liver microsomes was proven to be the N(+)-glucuronide by exhibiting the same HPLC retention time and electrospray ionization mass spectrum as the reference sample. The screening of 1-phenylimidazole against a panel of nine expressed human UDP-glucuronosyltransferases indicated the involvement of UGT1A3 and UGT1A4 in the formation of the N(+)-glucuronide metabolite.

Related Compounds

  • 1-Phenylimidazole

Related Articles:

Influence of inhibition of the metabolic activation on the mutagenicity of some nitrosamines, triazenes, hydrazines and seniciphylline in Drosophila melanogaster.

1988-11-01

[Mutat. Res. 202(1) , 251-67, (1988)]

Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles.

1993-05-05

[J. Biol. Chem. 268(13) , 9425-9, (1993)]

Three-dimensional pharmacophore hypotheses for the locust neuronal octopamine receptor (OAR3). Part 2: agonists.

1999-07-01

[Bioorg. Med. Chem. 7(7) , 1437-43, (1999)]

Acrolein genotoxicity in Drosophila melanogaster. III. Effects of metabolism modification.

1994-05-01

[Mutat. Res. 321(3) , 119-26, (1994)]

Chloroform-induced cytolethality in freshly isolated male B6C3F1 mouse and F-344 rat hepatocytes.

1998-04-01

[Toxicol. Appl. Pharmacol. 149(2) , 217-25, (1998)]

More Articles...